Last reviewed · How we verify
Lactic acid (Dermacid) — Competitive Intelligence Brief
phase 3
Alpha-hydroxy acid (AHA) / Keratolytic agent
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Lactic acid (Dermacid) (Lactic acid (Dermacid)) — Sanofi. Lactic acid works as a keratolytic and exfoliating agent that dissolves and removes damaged outer skin layers to promote skin renewal and improve texture.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lactic acid (Dermacid) TARGET | Lactic acid (Dermacid) | Sanofi | phase 3 | Alpha-hydroxy acid (AHA) / Keratolytic agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Alpha-hydroxy acid (AHA) / Keratolytic agent class)
- Sanofi · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lactic acid (Dermacid) CI watch — RSS
- Lactic acid (Dermacid) CI watch — Atom
- Lactic acid (Dermacid) CI watch — JSON
- Lactic acid (Dermacid) alone — RSS
- Whole Alpha-hydroxy acid (AHA) / Keratolytic agent class — RSS
Cite this brief
Drug Landscape (2026). Lactic acid (Dermacid) — Competitive Intelligence Brief. https://druglandscape.com/ci/lactic-acid-dermacid. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab